Molecular aspects of oral cancer

Anticancer Research

Volumn 22, Issue 5, 2002, Pages 2977-2980

  Nagler, Rafael M ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Genetics; Growth factors; Oncogenes; Oral cancer; SCC; Tumor markers

Indexed keywords

BLOOD GROUP ANTIGEN; CELL MARKER; CELL SURFACE MARKER; CYTOKERATIN; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; PROTEIN P53; TUMOR MARKER;

CELL SURFACE; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; GENETIC MARKER; HUMAN; MOLECULAR BIOLOGY; MOUTH CANCER; MOUTH CARCINOMA; PATIENT MONITORING; PLOIDY; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; REVIEW; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; UNITED STATES;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CELL DIVISION; GENES, TUMOR SUPPRESSOR; HUMANS; MOUTH NEOPLASMS; ONCOGENES;

EID: 0036765434     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Adhvaryu SG, Dave BG and Trivedi AH: Cytogenic surveillance of tabacco-areca nut (mava) chewers, including patients with oral cancer and premalignant conditions. Mutat Res 261: 41-49, 1991.
2. Kao-shan CS, Fine RL, Whang-Peng J, Lee EC and Chabner BA: Increased fragile sites and sister chromatid exchanges and peripheral blood of young cigarette smokers. Cancer Res 47: 6278-6282, 1987.
3. Bazopoulou-Kyrkanidou E, Garas J and Angelopoulos AP: SCE in lymphocytes of patients with oral carcinoma. Cancer Genet Cytogenet 20: 35-38, 1986.
4. Trivedi AH, Bhavana JD and Adhvaryu SG: Monitoring of smokeless tobacco consumers using cytogenetic end points. Anticancer Res 13: 2245-2250, 1993.
5. Popp W, Schell C, Kraus R, Vahrenholz C, Wolf R, Radtke J, Bierwirth K and Porpoth K: DNA strand breakage and DNA adducts in lymphocytes of oral cancer patients. Carcinogenesis 14: 2251-2256, 1993.
6. Popp W, Wolf R, Vahreholz C, Radtke J, Schell C, Kraus R, Brauksiepe G and Norpoth K: Sister chromatid exchange frequencies in lymphocytes of oral cancer patients seem to be influenced by drinking habits. Carcinogenesis 15: 1603-1607, 1994.
7. Volkes EE, Weichselbaum RR, Lippman SM and Hong WK: Medical progress - head and neck cancer. Review article. N Engl J Med 382: 184-192, 1993.
8. Nagler RM, Barak M, Peled M, Ben-Aryeh H, Filatov M and Laufer D: Early diagnosis and treatment monitoring roles of tumor markers Cyfra 21-1 and TPS in oral squamous cell carcinoma. Cancer 85(5): 1018-1025, 1999.
9. Kim J and Shin DM: Biomarkers of squamous cell carcinomas of the head and neck. Histol Histopathol 12: 205-218, 1997.
10. Lippman SM and Hong WK: Molecular biomarkers of the risk of oral cancer. N Eng J Med 344(17): 1323-1326, 2001.
11. Pillai MR, Ravi D and Nair MK: Chemoprevention of oral cancer: the need for effective biological monitoring. Sing Dent J 22: 6-12, 1997.
12. Voravud N: Chemoprevention in head and neck cancer. J Med Assoc Thai 79(3): 185-192, 1996.
13. Sudbo J, Kildal W, Risberg B, Koppand HS, Danielsen HE and Reith A: DNA content as a prognostic marker in patients with oral leukoplakia. N Eng J Med 344(17): 1270-1278, 2001.
14. Burkhardt A: Oncogenes and growth factor receptors as diagnostic and prognostic markers in precancers, and cancers of the oral mucosa. Cur Top Pathol 90: 223-239, 1996.
15. Schoelch ML, Regezi JA, Dekker NP, Ng IOL, McMillan A, Ziober BL, Le QT, Silverman S and Fu KK: Cell cycle proteins and the development of oral squamous cell carcinoma. Oral Oncol 35: 333-342, 1999.
16. Schoelch ML, Le QT, Silverman S, McMillan A, Dekker NP, Fu KK, Ziober BL and Regezi JA: Apoptosis-associated proteins and the development of oral squamous cell carcinoma. Oral Oncol 35: 77-85, 1999.
17. Warnakulasuriya S: Lack of molecular markers to predict malignant potential of oral precancer. J Pathol 190: 407-409, 2000.
18. Rassekh CH, Johnson JT and Eibling DE: Circulating markers in squamous cell carcinoma of the head and neck: a review. Oral Oncol, Eur J Cancer 30B(1): 23-28, 1994.
19. Lengauer C, Kinzler KW and Wogelstein B: Genetic instabilities in human cancers. Nature (London) 396: 643-649, 1998.
20. Miyagawa K: Genetic instability and cancer. Int J Hematol 67: 3-14, 1998.
21. Elledge SJ: Cell cycle checkpoints: preventing an identity crisis. Science 274: 1664-1672, 1996.
22. Winey M: Keeping the centrosome cycle on track. Genome stability. Curr Biol 6: 962-964, 1996.
23. Cowan JM: Cytogenetics in head and neck cancer. Otolaryngol Clin North Am 25: 1073-1087, 1992.
24. Saunders WS, Shuster M, Huang X, Gharaibeh B, Enyenihi AH, Petersen I and Gollin SM: Chromosomal instability and cytoskeletal defects in oral cancer cells. PNAS 97(1): 303-308, 2000.
25. Scully C and Field JK: Genetic aberrations in squamous cell carcinoma of the head and neck (SCCHN) with reference to oral carcinoma (Review). Int J Oncol 10: 5-21, 1997.
26. Tralongo V, Rodolico V, Luciani A, Marra G and Daniele E: Prognostic factors in oral squamous cell carcinoma. A review of the literature. Anticancer Res 19: 3503-3510, 1999.
27. Slaughter DP, Southwick HW and Smejkal W: Field cancerization in oral stratification squamous epithelium: clinical implications of multicentric origin. Cancer 6: 963-968, 1953.
28. Shin DM, Ginimez 113, Lee JS, Nishioka K, Wargovich MJ, Thacher S, Lotan R, Slaga TJ and Wong WK: Expression of epidermal growth factor receptor, polyamine levels, ornithine decarbosylase activity, micronuclei and transglutaminase I in a 7,12-dimethyl-benz [a] anthracene induced hamster buccal pouch carcinogenesis model. Cancer Res 50: 2505-2510, 1990.
29. Lippman MS and Hong WK: Differentiation therapy for head and neck cancer In: Snow G and Clark R, eds. Multimodality Therapy for Head and Neck Cancer. New York, Soringer -Verlag, 1992, pp 160-181.
30. Burge-Bottenbley A and Shklar G: Retardation of experimental oral cancer development by retinyl acetate. Nutr Cancer 5: 121-129, 1983.
31. Lippman SM and Hong WK: Retinoid Chemoprevention of upper aerodigestive tract carcinogenesis. In: De Vita VT Jr, Heilman S and Rosenberg SA, eds. Important Advances in Oncology. Philadelphia, Lippincott, 1992, pp 91-107.
32. Licciardello JTW, Spitz MR and Hong WK: Multiple primary cancer in patients with cancer of the head and neck, esophagus and lung. Int J Radiat Oncol Biol Phys 17: 467-476, 1989.